Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model.
Vizzutti F, Celsa C, Calvaruso V, Enea M, Battaglia S, Turco L, Senzolo M, Nardelli S, Miraglia R, Roccarina D, Campani C, Saltini D, Caporali C, Indulti F, Gitto S, Zanetto A, Di Maria G, Bianchini M, Pecchini M, Aspite S, Di Bonaventura C, Citone M, Guasconi T, Di Benedetto F, Arena U, Fanelli F, Maruzzelli L, Riggio O, Burra P, Colecchia A, Villa E, Marra F, Cammà C, Schepis F. Vizzutti F, et al. Among authors: di benedetto f, di bonaventura c, di maria g. Hepatology. 2023 Feb 1;77(2):476-488. doi: 10.1002/hep.32704. Epub 2022 Aug 17. Hepatology. 2023. PMID: 35921493
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.
Pipitone RM, Malvestiti F, Pennisi G, Jamialahmadi O, Dongiovanni P, Bertolazzi G, Pihlajamäki J, Yki-Järvinen H, Vespasiani-Gentilucci U, Tavaglione F, Maurotti S, Bianco C, Di Maria G, Enea M, Fracanzani AL, Kärjä V, Lupo G, Männistö V, Meroni M, Piciotti R, Qadri S, Zito R, Craxì A, Di Marco V, Cammà C, Tripodo C, Valenti L, Romeo S, Petta S, Grimaudo S. Pipitone RM, et al. Among authors: di marco v, di maria g. Liver Int. 2023 Aug;43(8):1761-1771. doi: 10.1111/liv.15586. Epub 2023 Apr 23. Liver Int. 2023. PMID: 37088979
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study.
Riggio O, Celsa C, Calvaruso V, Merli M, Caraceni P, Montagnese S, Mora V, Milana M, Saracco GM, Raimondo G, Benedetti A, Burra P, Sacco R, Persico M, Schepis F, Villa E, Colecchia A, Fagiuoli S, Pirisi M, Barone M, Azzaroli F, Soardo G, Russello M, Morisco F, Labanca S, Fracanzani AL, Pietrangelo A, Di Maria G, Nardelli S, Ridola L, Gasbarrini A, Cammà C. Riggio O, et al. Among authors: di maria g. Front Med (Lausanne). 2023 May 25;10:1184860. doi: 10.3389/fmed.2023.1184860. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37305121 Free PMC article.
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease.
Pennisi G, Enea M, Viganò M, Schepis F, de Ledinghen V, Berzigotti A, Wai-Sun Wong V, Fracanzani AL, Sebastiani G, Lara-Romero C, Bugianesi E, Svegliati-Baroni G, Marra F, Aghemo A, Valenti L, Calvaruso V, Colecchia A, Di Maria G, La Mantia C, Lin H, Mendoza YP, Pugliese N, Ravaioli F, Romero-Gomez M, Saltini D, Craxì A, Di Marco V, Cammà C, Petta S. Pennisi G, et al. Among authors: di maria g. JHEP Rep. 2023 Jun 7;5(9):100809. doi: 10.1016/j.jhepr.2023.100809. eCollection 2023 Sep. JHEP Rep. 2023. PMID: 37538247 Free PMC article.
Risk of liver-related events in metabolic dysfunction-associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria.
Pennisi G, Enea M, Romero-Gomez M, Bugianesi E, Wai-Sun Wong V, Fracanzani AL, de Ledinghen V, George J, Berzigotti A, Viganò M, Sebastiani G, Cannella R, Delamarre A, Di Maria G, Lange NF, Tulone A, Di Marco V, Cammà C, Petta S. Pennisi G, et al. Among authors: di maria g. Hepatology. 2024 Apr 1;79(4):912-925. doi: 10.1097/HEP.0000000000000616. Epub 2023 Oct 2. Hepatology. 2024. PMID: 37796137
Balancing Efficacy and Tolerability of First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis.
Celsa C, Cabibbo G, Pinato DJ, Di Maria G, Enea M, Vaccaro M, Battaglia S, Rizzo GEM, Giuffrida P, Giacchetto CM, Rancatore G, Grassini MV, Cammà C. Celsa C, et al. Among authors: di maria g. Liver Cancer. 2023 Jul 25;13(2):169-180. doi: 10.1159/000531744. eCollection 2024 Apr. Liver Cancer. 2023. PMID: 38751554 Free PMC article.
Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies.
Pennisi G, Infantino G, Celsa C, Di Maria G, Enea M, Vaccaro M, Cannella R, Ciccioli C, La Mantia C, Mantovani A, Mercurio F, Tilg H, Targher G, Di Marco V, Cammà C, Petta S. Pennisi G, et al. Among authors: di maria g. Liver Int. 2024 Nov;44(11):2939-2949. doi: 10.1111/liv.16075. Epub 2024 Aug 19. Liver Int. 2024. PMID: 39157862
Early hepatic decompensation identifies patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab or Sorafenib at highest risk of death.
Cabibbo G, Celsa C, Battaglia S, Enea M, Di Maria G, Grova A, Ciccia R, Manfredi GF, Iavarone M, Vogel A, Singal AG, Reig M, Pinato DJ, Cammà C. Cabibbo G, et al. Among authors: di maria g. Clin Cancer Res. 2024 Nov 22. doi: 10.1158/1078-0432.CCR-24-2582. Online ahead of print. Clin Cancer Res. 2024. PMID: 39576248
188 results